EP4017494

THE VMAT2 INHIBITOR VALBENAZINE FOR USE IN A METHOD OF TREATING A NEUROLOGICAL OR PSYCHIATRIC DISORDER IN PATIENTS WITH SEVERE RENAL IMPAIRMENT

  • :
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • :
    21.8.2020
  • :
    20.8.2025
  • :
    20764910.4
  • :
    20.8.2040
  • :
    19.12.2025
  • :
    THE VMAT2 INHIBITOR VALBENAZINE FOR USE IN A METHOD OF TREATING A NEUROLOGICAL OR PSYCHIATRIC DISORDER IN PATIENTS WITH SEVERE RENAL IMPAIRMENT

21.8.2020
20.8.2025
19.12.2025
  • :
    Neurocrine Biosciences, Inc.
  • :
    6027 Edgewood Bend Court, San Diego, CA 92130, US
  • :
    LOEWEN, Gordon Raphael
  • :
    Solana Beach, California 92075, US
  • :
    LUO, Sha Rosa
  • :
    San Diego, California 92130, US
  • :
    201962890697 P
  • :
    23.8.2019
  • :
    US
  • :
    202063028754 P
  • :
    22.5.2020
  • :
    US
  • :
    US2020047392
  • :
    21.8.2020
  • :
    A61K 31/4738, A61P 13/12, A61P 25/00, A61P 25/14, A61P 25/16, A61P 25/24, A61P 25/28, A61K 9/00